Your browser is no longer supported. Please, upgrade your browser.
Settings
ICAD iCAD, Inc. daily Stock Chart
ICAD [NASD]
iCAD, Inc.
Index- P/E14.11 EPS (ttm)0.22 Insider Own17.05% Shs Outstand17.26M Perf Week-6.08%
Market Cap53.33M Forward P/E- EPS next Y-0.07 Insider Trans0.00% Shs Float14.18M Perf Month3.34%
Income3.60M PEG0.94 EPS next Q-0.08 Inst Own22.60% Short Float0.20% Perf Quarter3.00%
Sales27.40M P/S1.95 EPS this Y146.80% Inst Trans-0.03% Short Ratio0.64 Perf Half Y-11.08%
Book/sh0.65 P/B4.75 EPS next Y81.10% ROA-49.10% Target Price6.50 Perf Year-33.41%
Cash/sh0.45 P/C6.84 EPS next 5Y15.00% ROE-113.60% 52W Range2.80 - 4.78 Perf YTD-10.17%
Dividend- P/FCF- EPS past 5Y18.50% ROI24.50% 52W High-35.15% Beta0.81
Dividend %- Quick Ratio1.40 Sales past 5Y-0.10% Gross Margin66.70% 52W Low10.71% ATR0.16
Employees119 Current Ratio1.60 Sales Q/Q-3.10% Oper. Margin-55.40% RSI (14)50.65 Volatility4.69% 5.68%
OptionableYes Debt/Eq0.56 EPS Q/Q61.80% Profit Margin-56.50% Rel Volume2.35 Prev Close3.09
ShortableYes LT Debt/Eq0.50 EarningsNov 13 AMC Payout- Avg Volume44.56K Price3.10
Recom2.00 SMA20-0.19% SMA503.35% SMA200-4.24% Volume45,715 Change0.32%
Dec-09-08Reiterated Canaccord Adams Buy $5 → $3.50
Aug-01-08Reiterated MDB Capital Group Buy $5.50 → $6
May-14-08Reiterated Canaccord Adams Buy $4 → $4.50
Feb-14-08Initiated Sun Trust Rbsn Humphrey Buy $4
Jan-24-07Reiterated Dawson James Speculative Buy $4 → $5
Oct-11-18 08:00AM  iCAD Announces Exceptional Study Results Demonstrating Significant Advantages of Revolutionary Artificial Intelligence Technology for Digital Breast Tomosynthesis GlobeNewswire +8.31%
Oct-09-18 08:00AM  SUNY Upstate Medical University Selects iCADs Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment GlobeNewswire
Oct-03-18 08:00AM  Sanford Health Announces Adoption of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment GlobeNewswire
Oct-01-18 02:35PM  Independent, Long-Term Study Highlights Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment GlobeNewswire
Sep-20-18 11:24AM  iCAD Inc (NASDAQ:ICAD): Risks You Need To Consider Before Buying Simply Wall St.
Sep-04-18 11:15AM  ICAD: U.S. Tomo 2.0, Organic Therapy Growth and Leaner Ops Mean Profitability is Realistic Zacks Small Cap Research
Aug-31-18 08:07AM  Edited Transcript of ICAD earnings conference call or presentation 14-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-29-18 08:00AM  iCAD Announces AERB Approval of Xoft System in India GlobeNewswire
Aug-28-18 08:00AM  Medical City Plano, a HCA Healthcare Facility, Adopts iCADs Xoft Electronic Brachytherapy System for Treatment of Early-Stage Breast Cancer GlobeNewswire
07:00AM  Arcturus Therapeutics Appoints Andrew Sassine as Interim Chief Financial Officer GlobeNewswire
Aug-14-18 04:13PM  Icad: 2Q Earnings Snapshot Associated Press
04:01PM  iCAD Reports Second Quarter 2018 Financial Results GlobeNewswire
Aug-08-18 09:14AM  ICAD's stock soars after FDA clearance of breast-density AI software product MarketWatch +7.77%
08:00AM  iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis GlobeNewswire
Aug-07-18 08:00AM  iCAD to Report Second Quarter and Six Months Ended June 30, 2018 Financial Results on Tuesday, August 14th GlobeNewswire
Jun-26-18 01:57PM  What Does iCAD Incs (NASDAQ:ICAD) Share Price Indicate? Simply Wall St.
Jun-06-18 08:00AM  iCAD Named 2018 MedTech Breakthrough Award Winner GlobeNewswire
May-22-18 09:20AM  ICAD: Q1 2018 Results: Detection Disappointing But Still Looking For 2.0-Related Inflection in 2H Zacks Small Cap Research
May-21-18 10:03PM  Edited Transcript of ICAD earnings conference call or presentation 14-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-14-18 04:39PM  Icad: 1Q Earnings Snapshot Associated Press
04:01PM  iCAD Reports First Quarter 2018 Financial Results GlobeNewswire
12:15PM  iCAD, Inc. to Host Earnings Call ACCESSWIRE
09:55AM  iCAD Inc (NASDAQ:ICAD): Time For A Financial Health Check Simply Wall St.
May-08-18 08:00AM  iCAD to Report First Quarter 2018 Financial Results on Monday, May 14, 2018 GlobeNewswire
Apr-19-18 08:00AM  iCAD Announces Presentation of Positive Clinical Data on Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers at ESTRO 37 GlobeNewswire
Apr-12-18 07:40AM  Free Post Earnings Research Report: Nutanixs Revenues Surged 44%; Net Loss Narrowed ACCESSWIRE
Apr-03-18 09:45AM  ICAD: Q4 2017 Results: Tomo Seeing Strong Demand. Plug Pulled on Unprofitable Skin Subscription Biz Zacks Small Cap Research
Mar-23-18 07:21PM  Edited Transcript of ICAD earnings conference call or presentation 22-Mar-18 8:30pm GMT Thomson Reuters StreetEvents
07:23AM  3 Stocks to Watch on Friday: At Home Group Inc (HOME), HTG Molecular Diagnostics Inc (HTGM) and iCAD Inc (ICAD) InvestorPlace
Mar-22-18 04:01PM  iCAD Reports Fourth Quarter and Full-Year 2017 Financial Results GlobeNewswire
01:00PM  iCAD, Inc. to Host Earnings Call ACCESSWIRE
Mar-16-18 08:00AM  iCAD to Report Fourth Quarter and Fiscal 2017 Financial Results on Thursday, March 22, 2018 GlobeNewswire
Mar-01-18 02:00AM  iCAD Granted CE Mark Approval in Europe for PowerLook Tomo Detection 2.0 Artificial Intelligence Solution GlobeNewswire +7.00%
Feb-08-18 10:31AM  iCAD Named a Top Artificial Intelligence Medical Imaging Solution Provider by Healthcare Tech Outlook GlobeNewswire +6.34%
Dec-15-17 10:00AM  ICAD: Study Shows IORT Superior To EBRT in Quality of Life, Cost Zacks Small Cap Research
Dec-12-17 08:00AM  Two Centers from The US Oncology Network Adopt iCADs Xoft Electronic Brachytherapy System for Treatment of Early-Stage Non-Melanoma Skin Cancer GlobeNewswire +7.78%
Dec-07-17 08:00AM  iCAD Announces Study Demonstrating Economic and Health Benefits of Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer Treatment GlobeNewswire +10.26%
Nov-27-17 08:00AM  iCADs PowerLook® Tomo Detection Experiences Growing Adoption GlobeNewswire
Nov-21-17 07:49PM  Are iCAD Incs (ICAD) Interest Costs Too High? Simply Wall St. +5.08%
Nov-20-17 10:30PM  Edited Transcript of ICAD earnings conference call or presentation 8-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-13-17 05:30PM  ICAD: Q3 Detection and Therapy Results Solid. Tomo Growth To Accelerate Zacks Small Cap Research
Nov-09-17 08:00AM  iCAD Announces Positive Clinical Data on Xoft System for Non-Melanoma Skin Cancer Treatment Selected as Best of ASTRO 2017 GlobeNewswire -10.84%
Nov-08-17 04:01PM  iCAD Reports Third Quarter 2017 Financial Results GlobeNewswire
01:30PM  iCAD, Inc. to Host Earnings Call ACCESSWIRE
08:00AM  Imaging for Women Now Offering iCADs PowerLook® Tomo Detection for Digital Breast Tomosynthesis GlobeNewswire
Nov-01-17 08:00AM  iCAD to Report Third Quarter 2017 Financial Results on Wednesday, November 8 GlobeNewswire
Oct-26-17 08:00AM  iCADs PowerLook Tomo Detection for Digital Breast Tomosynthesis Named 2017 Product of the Year by New Hampshire High Technology Council GlobeNewswire
Sep-25-17 08:00AM  iCAD Announces Presentation of New Clinical Data on Xoft System for Treatment of Nonmelanoma Skin Cancer and Early-Stage Breast Cancer at ASTRO 2017 GlobeNewswire
Sep-20-17 08:00AM  iCAD to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-05-17 08:58PM  ETFs with exposure to iCAD, Inc. : September 6, 2017 Capital Cube
Sep-03-17 08:00PM  iCAD Announces Approval of Xoft® Axxent® Balloon Applicators by China Food & Drug Administration for Treatment of Early-Stage Breast Cancer GlobeNewswire
Aug-31-17 12:42PM  iCAD, Inc. :ICAD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 31, 2017 Capital Cube +6.74%
Aug-30-17 08:00AM  iCAD Announces Approval of Xoft® Axxent® Balloon Applicators by China Food & Drug Administration for Treatment of Early-Stage Breast Cancer GlobeNewswire +10.75%
Aug-17-17 06:16PM  Edited Transcript of ICAD earnings conference call or presentation 8-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
10:20AM  ICAD: A Look Behind Q2 Numbers. U.S. Tomo Launch Encouraging Zacks Small Cap Research
Aug-08-17 04:01PM  iCAD Reports Second Quarter 2017 Financial Results and Announces $13 Million Credit Facility With Silicon Valley Bank GlobeNewswire
10:10AM  Investor Network: iCAD, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-17 08:00AM  iCAD to Present at the Canaccord Genuity 37th Annual Growth Conference GlobeNewswire
Jul-31-17 08:00AM  iCAD to Report Second Quarter 2017 Financial Results on Tuesday, August 8 GlobeNewswire
Jul-27-17 08:00AM  Researchers to Present Clinical Data Supporting Use of Xoft System for Endometrial Cancer Treatment at American Association of Physicists in Medicine Annual Meeting & Exhibition GlobeNewswire
Jul-19-17 08:00AM  iCAD announces positive study results comparing use of companys Xoft® Axxent® Electronic Brachytherapy (eBx®) System® to Mohs surgery in treatment of early-stage non-melanoma skin cancer GlobeNewswire
Jun-06-17 08:00AM  Carolina Breast Imaging Specialists Adopts iCADs Advanced Artificial Intelligence Technology for Digital Breast 3D Tomosynthesis GlobeNewswire
May-26-17 01:11PM  ETFs with exposure to iCAD, Inc. : May 26, 2017 Capital Cube
May-25-17 08:48AM  iCAD, Inc. :ICAD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 25, 2017 Capital Cube
May-22-17 08:00AM  iCAD to Participate in Two Upcoming Investor Conferences GlobeNewswire
May-08-17 10:00AM  ICAD: Q1: Strong Detection Offsets Weakness in NMSC Revenue Zacks Small Cap Research
May-05-17 02:25PM  Edited Transcript of ICAD earnings conference call or presentation 2-May-17 8:30pm GMT Thomson Reuters StreetEvents +7.06%
09:00AM  ICAD: U.S. Tomo Launched, Should Be 2017 Catalyst Zacks Small Cap Research
08:02AM  First-Ever European Analysis of Electronic Brachytherapy Using the Xoft System for Endometrial and Cervical Cancer Treatment to be Presented at European Society for Radiotherapy & Oncology Meeting GlobeNewswire
08:00AM  First-Ever European Analysis of Electronic Brachytherapy Using the Xoft System for Endometrial and Cervical Cancer Treatment to be Presented at European Society for Radiotherapy & Oncology Meeting GlobeNewswire
May-02-17 04:01PM  iCAD Reports First-Quarter 2017 Financial Results GlobeNewswire
08:25AM  Investor Network: iCAD, Inc. to Host Earnings Call Accesswire
May-01-17 08:00AM  iCAD Announces First Early-Stage Breast Cancer Patient Treated with Intraoperative Radiation Therapy Using the Xoft System at Monash Cancer Centre, a partnership between Peter MacCallum Cancer Centre and Monash Health in Australia GlobeNewswire
Apr-26-17 08:00AM  iCAD to Showcase Breakthrough Early-Stage Breast Cancer Treatment Utilizing the Xoft System at American Society of Breast Surgeons (ASBrS) Annual Meeting PR Newswire +5.45%
Apr-24-17 08:00AM  iCAD to Report First Quarter 2017 Financial Results on Tuesday, May 2 GlobeNewswire
Apr-20-17 08:00AM  Researchers to Present Updated Clinical Data on Intraoperative Radiation Therapy Using the Xoft System at American Brachytherapy Society (ABS) Annual Meeting PR Newswire
Apr-11-17 03:00PM  ICAD: Tomo FDA Approval Sets Stage For Next Growth Phase Zacks Small Cap Research
Apr-06-17 08:00AM  iCAD To Showcase PowerLook Tomo Detection Technology At SBI/ACR Breast Imaging Symposium PR Newswire +11.39%
Apr-05-17 04:54PM  ETFs with exposure to iCAD, Inc. : April 5, 2017 Capital Cube
Mar-30-17 01:04PM  ICAD INC Financials
09:08AM  iCAD, Inc. :ICAD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 30, 2017 Capital Cube
Mar-27-17 01:36PM  iCAD Cancer Detecting Product Gets FDA Premarket OK Investopedia +14.87%
08:00AM  iCAD Receives FDA Approval For PowerLook Tomo Detection PR Newswire
Mar-24-17 03:51PM  ICAD INC Files SEC form 10-K, Annual Report
Mar-14-17 11:00AM  ICAD: NMSC Utilization Revenue Ramp Taking Longer Zacks Small Cap Research
Mar-09-17 05:14PM  ICAD INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +12.89%
08:00AM  iCAD Announces More Than 3,000 Early-Stage Breast Cancer Patients Treated with Intraoperative Radiation Therapy Using the Xoft System PR Newswire
Mar-08-17 04:01PM  iCAD Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 ICAD Inc Earnings Release - After Market Close
Mar-03-17 08:00AM  iCAD Showcases Targeted, Non-Surgical Non-Melanoma Skin Cancer Treatment at AAD 2017 PR Newswire
Mar-02-17 04:05PM  iCAD to Present at the 29th Annual ROTH Conference GlobeNewswire
Feb-27-17 09:00AM  iCAD to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call on Wednesday, March 8, 2017 GlobeNewswire
Feb-08-17 04:15PM  ICAD: Certain Catalysts Expected to Return ICAD to Positive Revenue Growth in 2017 Zacks Small Cap Research
Feb-03-17 10:10AM  ICAD INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets
Dec-28-16 01:47PM  ICAD INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Dec-22-16 02:04PM  ICAD INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Dec-16-16 04:53PM  ICAD INC Files SEC form 8-K, Other Events
Dec-06-16 08:00AM  First-Ever Analysis of Intraoperative Radiation Therapy with Xoft System as a Boost Prior to Whole Breast Radiation to be Presented at San Antonio Breast Cancer Symposium PR Newswire +5.71%
Nov-30-16 04:05PM  iCAD to Present at the 9th Annual LD Micro Main Event Accesswire
Nov-28-16 11:23AM  Edited Transcript of ICAD earnings conference call or presentation 2-Nov-16 12:30pm GMT
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. It operates through two segments, Cancer Detection and Cancer Therapy. The company provides electronic brachytherapy (eBX) products, including Axxent eBx systems for the treatment of early stage breast cancer, endometrial cancer, cervical cancer, and skin cancer, as well as for treating other cancers or conditions where radiation therapy is indicated comprising intraoperative radiation therapy. It also offers digital mammography computer-aided detection (CAD) products, such as advanced image analysis and workflow solutions in breast imaging, which include PowerLook Mammo Detection, which detects and identifies suspicious masses and micro-calcifications; and PowerLook Advanced Mammography Platform, a computer server residing on a customer's network that receives patient studies from the imaging modality, performs CAD and density assessment analysis, and sends the CAD results to picture archiving and communication system and/or review workstations. In addition, the company's digital mammography CAD products comprise magnetic resonance imaging products to detect breast and prostate cancer; breast tomosynthesis systems; and advanced image analysis and workflow solutions in computed tomography (CT) colonography, including VeraLook that supports the detection of colonic polyps in conjunction with CT colonography. It serves hospitals, ambulatory care centers and free standing radiation oncology facilities, and other office-based uses through sales organizations, as well as through various original equipment manufacturer partners, distributors, and resellers. iCAD, Inc. has a strategic partnership agreement with Invivo Corp. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was founded in 1984 and is headquartered in Nashua, New Hampshire.